An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis
Angelo Luca, Berhard Angermayr, Guido Bertolini, Franz Koenig, Giovanni Vizzini, Martin Ploner, Markus Peck‐Radosavljevic, Bruno Gridelli, Jaime Bosch – 30 July 2007 – The Model for End‐Stage Liver Disease (MELD) is widely used to predict the short‐term mortality in patients with cirrhosis, but potential limitations of this score have been reported. The aim of this study was to improve the score's prognostic accuracy by assessing new objective variables.